Business Context and Reporting Period
This Form 8-K filing by Ocular Therapeutix, Inc. reports on the Annual Meeting of Stockholders held on June 11, 2015. The company is incorporated in Delaware and is headquartered in Bedford, MA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
No material financial changes were reported in this filing. The document details the outcomes of shareholder votes regarding board composition and auditor ratification.
Corporate Governance and Voting Results
- Director Elections: Stockholders elected James Garvey and Charles Warden as Class I directors to serve until the 2018 Annual Meeting.
- James Garvey: 16,954,097 votes for; 899,977 votes withheld; 1,381,753 broker non-votes.
- Charles Warden: 17,373,126 votes for; 480,948 votes withheld; 1,381,753 broker non-votes.
- Auditor Ratification: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm.
- Results: 19,221,325 votes for; 14,502 votes against; 0 abstentions; 0 broker non-votes.
Investor Verification Checklist
- Verify the official appointment of James Garvey and Charles Warden to the Board of Directors.
- Confirm the engagement of PricewaterhouseCoopers LLP for the current fiscal year audit.
- Review the company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K does not contain them.